How GLP-1 receptor agonists work for weight loss

Overview

GLP-1 receptor agonists copy a natural gut hormone called glucagon-like peptide-1, which your bowel releases within minutes of eating. The medicine keeps that satiety signal switched on for a whole week instead of a few minutes.

Why it's done and who it helps

• GLP-1 acts on appetite centres in the hypothalamus, reducing hunger and food noise.
• Gastric emptying slows, so meals feel filling for longer.
• Insulin release becomes more glucose-dependent, which lowers blood sugar without much hypoglycaemia risk.
• Weight loss comes from eating less, not from burning more calories.

What happens in the first four weeks

Most people notice smaller portions and less snacking within two to four weeks of the first injection. Early weight change is modest and partly fluid, which is why we judge response at 12 and 26 weeks rather than week four.

Why it is a weekly injection

Both semaglutide and tirzepatide are engineered to resist rapid breakdown, giving a half-life of around five days. That allows once-weekly subcutaneous dosing into the abdomen, thigh or upper arm.

What it does not do

GLP-1 therapy does not repair kidney damage, replace dialysis, or work without dietary and activity change. Used alone it typically stalls once appetite adapts, which is why structured review matters.

Preparing for your appointment

How quickly will I feel a difference?

Appetite change is often noticeable within the first two to three injections; meaningful weight change usually takes eight to twelve weeks.

Is it the same as insulin?

No. GLP-1 medicines are not insulin and are given weekly, not with meals.

When to contact your care team

Contact the clinic promptly if you have any of the following:

• Vomiting or diarrhoea lasting more than 24 hours, or you cannot keep fluids down
• Passing much less urine than usual, or new swelling of the legs or face
• Severe pain in the upper abdomen that spreads to your back, with or without vomiting
• A weight change of more than 2 kg in a week that is not explained by fluid
• A missed weekly weight, a missed dose, or any hospital admission

If you are seriously unwell, contact NHS 111 or your renal unit directly rather than waiting for your next review.

Your care at KidneyWeight Clinic

Every dose change, weekly weight and kidney blood test is recorded in your clinical monitoring record, reviewed by Professor Mohammed Mahdi Althaf at six-weekly intervals and formally reassessed at 26 weeks. Booking and your initial payment are handled by professoralthaf.co.uk, medication supply by Healist Pharmacy, and follow-up appointment payments by Carebit.

References

• NICE TA1026: tirzepatide for managing overweight and obesity
• NICE TA875: semaglutide for managing overweight and obesity
• NICE CG189: obesity identification, assessment and management
• NHS: weight-loss medicines

This article is general patient information reviewed by a consultant nephrologist. It is not individual medical advice; treatment decisions are made at a face-to-face consultation.